Literature DB >> 28111883

Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years.

Antonio Ascione1, Luca Fontanella1, Michele Imparato1, Luca Rinaldi2, Massimo De Luca3.   

Abstract

BACKGROUND & AIMS: Cirrhosis (LC) and hepatocellular carcinoma (HCC) are highly prevalent in Europe, with accompanying high mortality rates and social costs. As epidemiological data on these diseases are scarce, age-standardized death rate (ASDR) can serve as an indirect assessment of their burden.
METHODS: We analysed the ASDRs for LC and HCC from data reported in the WHO official death registries from 1970 to 2010, and compared ASDRs over the decades. The European Detailed Mortality Database was also used as source of data.
RESULTS: In 1970, Portugal had the highest reported mortality for LC, followed by France and Italy. However, in 2010, Finland, Austria and Germany were respectively the three highest, while the UK showed the highest increase over those four decades (+284.8%). The annual ASDRs for LC have dropped in Europe from 20.4/105 inhabitants in 1970 to 9.6 in 2010; a 53% decrease. For HCC, Spain, Italy and Denmark were ranked first through third, while in 2010 Italy, France and Luxembourg replaced them. Portugal had the highest increase (+654.7%). In 1980-2010, the ASDR for HCC in Europe increased from 3.4/105 inhabitants to 6.3, up 85.4%. In the majority of nations-except for the UK, Finland and Ireland-there was a decrease in LC mortality and an increase for HCC mortality.
CONCLUSIONS: The LC mortality rate is decreasing in Europe, yet there is a significant increase in HCC mortality. This phenomenon requires greater attention so we can understand the risk factors and implement preventive measures.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  age-standardized death rate; cirrhosis mortality; hepatocellular carcinoma mortality; liver disease mortality

Mesh:

Year:  2017        PMID: 28111883     DOI: 10.1111/liv.13371

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

Review 1.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

2.  Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.

Authors:  Antonio Ascione; Massimo De Luca; Mario Melazzini; Simona Montilla; Maria Paola Trotta; Salvatore Petta; Massimo Puoti; Vincenzo Sangiovanni; Vincenzo Messina; Savino Bruno; Antonio Izzi; Erica Villa; Alessio Aghemo; Anna Linda Zignego; Alessandra Orlandini; Luca Fontanella; Antonio Gasbarrini; Marco Marzioni; Edoardo G Giannini; Antonio Craxì
Journal:  Infection       Date:  2018-05-28       Impact factor: 7.455

3.  Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.

Authors:  Shintaro Ichikawa; Utaroh Motosugi; Hiroyuki Morisaka; Kazuto Kozaka; Satoshi Goshima; Tomoaki Ichikawa
Journal:  Magn Reson Med Sci       Date:  2020-02-27       Impact factor: 2.471

4.  Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis.

Authors:  Paolo Maggi; Federica Calò; Vincenzo Messina; Gianfranca Stornaiuolo; Maria Stanzione; Luca Rinaldi; Stefania De Pascalis; Margherita Macera; Nicola Coppola
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

5.  Morbimortality Associated with Liver Cirrhosis in Peru: An Ecological Analysis for the Period of 2004-2016.

Authors:  Daniela Rojas-Acuña; Nilo Polo-Samillan; Angie Z Vasquez-Chavesta; Crist Escalante-Arias; Cristhian J Rios-Perez; Carlos J Toro-Huamanchumo
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

Review 6.  Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer.

Authors:  Joanne Marie O'Rourke; Vandana Mridhu Sagar; Tahir Shah; Shishir Shetty
Journal:  World J Gastroenterol       Date:  2018-10-21       Impact factor: 5.742

7.  A Novel Risk Score to Predict Post-Trauma Mortality in Nonagenarians.

Authors:  Anthony Kopatsis; Vishaka K Chetram; Katherine Kopatsis; Nicholas Morin; Christine Wagner
Journal:  J Emerg Trauma Shock       Date:  2019 Jul-Sep

8.  Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.

Authors:  Yue Gu; Xueqin Yang; Hang Liang; Deli Li
Journal:  BMC Gastroenterol       Date:  2019-12-30       Impact factor: 3.067

9.  Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy.

Authors:  Davide Giuseppe Ribaldone; Gian Paolo Caviglia; Silvia Gaia; Emanuela Rolle; Alessandra Risso; Daniela Campion; Paola Rita Brunocilla; Giorgio Maria Saracco; Patrizia Carucci
Journal:  Curr Oncol       Date:  2022-02-24       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.